华检医疗(01931.HK)公布，易笑女士已获委任为公司执行董事兼首席科学家，自2026年2月6日起生效

Group 1 - The company Huajian Medical (01931.HK) announced the appointment of Ms. Yi Xiao as the Executive Director and Chief Scientist, effective from February 6, 2026 [1] - As of the market close on February 6, 2026, Huajian Medical's stock price was HKD 1.19, reflecting a decrease of 7.03%, with a trading volume of 7.49 million shares and a turnover of HKD 9.1961 million [1] - There has been low attention from investment banks towards the stock, with no ratings provided in the last 90 days [1] Group 2 - Huajian Medical has a market capitalization of HKD 20.53 billion, ranking 4th in the pharmaceutical commercial II industry [2]